SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE576.3021.7 (+3.91 %)
PREV CLOSE ( ) 554.60
OPEN PRICE ( ) 551.00
BID PRICE (QTY) 576.30 (3032)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 864771
TODAY'S LOW / HIGH ( )548.00 580.00
52 WK LOW / HIGH ( )433.15 608.55
NSE577.2522.75 (+4.1 %)
PREV CLOSE( ) 554.50
OPEN PRICE ( ) 553.00
BID PRICE (QTY) 577.25 (9605)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9935404
TODAY'S LOW / HIGH( ) 547.65 581.80
52 WK LOW / HIGH ( )432.7 608.95
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
14Jun Sun Pharma trades higher on the bourses
Sun Pharmaceutical Industries is currently trading at Rs. 556.75, up by..
13Jun Sun Pharma receives EIR from USFDA for
Sun Pharmaceutical Industries has received the Establishment Inspection..
13Jun Sun Pharma spurts on receiving EIR fro
Sun Pharmaceutical Industries is currently trading at Rs. 549.70, up by..
11Jun Sun Pharma, Tata Motors and SBI to see
Sun Pharma racked up its biggest rally in four months, soaring over 8 pe..
05Jun Sun Pharma receives CSR Award from FGI
Sun Pharmaceutical Industries has received a Corporate Social Responsibi..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit1762.6-4945.9
Gross Profit 1510.5 -5199.8
Operating Profit 3731.112510.6
Net Sales 22831.879476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7430.85 (1.82%)
M.Cap (Rs. in Cr)15790.04
Astrazeneca Pharma I (BSE)
 1478.55 (9.32%)
M.Cap (Rs. in Cr)3696.38
Piramal Enterprises (BSE)
 2602.35 (2.48%)
M.Cap (Rs. in Cr)46996.49
Glaxosmithkline Phar (BSE)
 2801.00 (0.70%)
M.Cap (Rs. in Cr)23725.32
Dr. Reddys Lab (BSE)
 2334.95 (0.79%)
M.Cap (Rs. in Cr)38753.92
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 13.07%
MUTUAL FUNDS/UTI 8.22%
FI/BANKS/INSURANCE 7.94%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.